Chembio Diagnostics to Report First Quarter 2021 Financial Results on May 6, 2021
April 22 2021 - 8:00AM
Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care
diagnostics company focused on infectious diseases, announced today
that it will release financial results for the first quarter of
2021 after the close of trading on Thursday, May 6, 2021.
The company’s management team will host a corresponding
conference call beginning at 4:30 p.m. Eastern Time on May 6, 2021.
Investors interested in listening to the conference call may do so
by dialing 877-545-0320 from the US or 973-528-0016 from outside
the US and providing Entry Code: 562459 or by accessing
www.chembio.com/investors/calendar-of-events/. A replay of the call
will be available by dialing 877-481-4010 from the US or
919-882-2331 from outside the US using passcode 40896 or by
accessing www.chembio.com/investors/calendar-of-events/.
About Chembio DiagnosticsChembio is a leading
point-of-care diagnostics company focused on detecting and
diagnosing infectious diseases, including COVID-19, sexually
transmitted disease, and fever and tropical disease. Coupled with
Chembio’s extensive scientific expertise, its novel DPP technology
offers broad market applications beyond infectious disease.
Chembio’s products are sold globally, directly and through
distributors, to hospitals and clinics, physician offices, clinical
laboratories, public health organizations, government agencies, and
consumers. Learn more at www.chembio.com.
DPP is Chembio’s registered trademark, and the Chembio logo is
Chembio’s trademark. For convenience, these trademarks appear in
this release without ® or ™ symbols, but that practice does not
mean that Chembio will not assert, to the fullest extent under
applicable law, its rights to the trademarks.
Investor contact:Philip TaylorGilmartin
Group(415) 937-5406investor@chembio.com
Chembio Diagnostics (NASDAQ:CEMI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Chembio Diagnostics (NASDAQ:CEMI)
Historical Stock Chart
From Apr 2023 to Apr 2024